S100B and non-small cell lung carcinoma: For example, Pang et al. reported that NSCLC patients with IMD had a serum S100B concentration of 0.048 ± 0.0029 μg/L, while those without IMD had a serum S100B concentration of 0.015 ± 0.0160 μg/L (p ≤ 0.01) [89].